US Patent 9453076 Anti-TLR4 antibodies and uses thereof
Patent 9453076 was granted and assigned to Novimmune on September, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 29, 2013
Date of Patent
September 27, 2016
Patent Applicant
Patent Application Number
13853158
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9453076 Anti-TLR4 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.